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Abstract 
Background: Females with elevated androgens can suffer from hirsutism, the most common clinical 
manifestation of hyperandrogenemia. Hirsutism affects 5 to 10% of females and is defined as excessive 
hair growth in females in a male pattern, for example excess hair growth on the jaw, neck, chest or back. 
Other clinical manifestations of elevated androgens include alopecia, acne and ovulatory and menstrual 
irregularities. Spearmint tea has been shown to lower androgenic hormones in rats prompting the more 
recent studies involving humans. If spearmint tea is effective in treating hirsutism and elevated 
androgens it may have the potential to become a first-line, low risk, non-pharmaceutical treatment option. 
Methods: An exhaustive search was conducted using MEDLINE-Ovid, Web of Science, CINAHL and 
Google Scholar using the keywords hirsutism, spearmint tea (mentha spicata) and androgens. The 
Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach was used to 
assess the quality of the relevant articles. A search was conducted of the National Institute of Health 
clinical trials website and no current trials related to anti-androgenic effects of spearmint tea were noted. 
Results: The initial search resulted in 4 articles for analysis. Two articles met the inclusion criteria and 
were included in this review. The first study revealed a decrease in free testosterone and an increase in 
luteinizing hormone and follicle stimulating hormone over a 5-day period of drinking spearmint tea. 
Hirsutism was not scored at the end of the trial. The second study, a randomized controlled trial, 
demonstrated a decrease in free testosterone and total testosterone and an increase in luteinizing 
hormone and follicle stimulating hormone over a 30-day period of drinking spearmint tea. The study 
demonstrated a reduction in the self-reported scoring for hirsutism but noted no significant change in the 
more objective Ferriman-Gallwey score. 
Conclusion: Spearmint tea may be useful in lowering androgenic hormones for female patients suffering 
from the effects of hirsutism and other symptoms associated with elevated androgens. In order to see 
benefits in the hirsute patient, it is likely that longer treatment time is necessary as well as extended 
follow up time with patients to monitor symptomatic improvement. 
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Abstract 
Background: Females with elevated androgens can suffer from hirsutism, the 
most common clinical manifestation of hyperandrogenemia. Hirsutism affects 5 
to 10% of females and is defined as excessive hair growth in females in a male 
pattern, for example excess hair growth on the jaw, neck, chest or back. Other 
clinical manifestations of elevated androgens include alopecia, acne and 
ovulatory and menstrual irregularities. Spearmint tea has been shown to lower 
androgenic hormones in rats prompting the more recent studies involving 
humans. If spearmint tea is effective in treating hirsutism and elevated 
androgens it may have the potential to become a first-line, low risk, non-
pharmaceutical treatment option.  
Methods:  An exhaustive search was conducted using MEDLINE-Ovid, Web of 
Science, CINAHL and Google Scholar using the keywords hirsutism, spearmint 
tea (mentha spicata) and androgens. The Grading of Recommendations, 
Assessment, Development and Evaluation (GRADE) approach was used to assess 
the quality of the relevant articles. A search was conducted of the National 
Institute of Health clinical trials website and no current trials related to anti-
androgenic effects of spearmint tea were noted. 
Results:  The initial search resulted in 4 articles for analysis. Two articles met 
the inclusion criteria and were included in this review. The first study revealed a 
decrease in free testosterone and an increase in luteinizing hormone and follicle 
stimulating hormone over a 5-day period of drinking spearmint tea. Hirsutism 
was not scored at the end of the trial. The second study, a randomized controlled 
trial, demonstrated a decrease in free testosterone and total testosterone and an 
increase in luteinizing hormone and follicle stimulating hormone over a 30-day 
period of drinking spearmint tea. The study demonstrated a reduction in the self-
reported scoring for hirsutism but noted no significant change in the more 
objective Ferriman-Gallwey score.  
Conclusion:  Spearmint tea may be useful in lowering androgenic hormones for 
female patients suffering from the effects of hirsutism and other symptoms 
associated with elevated androgens. In order to see benefits in the hirsute patient, 
it is likely that longer treatment time is necessary as well as extended follow up 
time with patients to monitor symptomatic improvement.   
Keywords:  Hirsutism, spearmint tea, androgens 
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Anti-Androgenic Effects of Spearmint Tea (Mentha 
Spicata) 
BACKGROUND 
Females with elevated androgens can suffer from hirsutism, the most 
common clinical manifestation of hyperandrogenemia.1 Hirsutism affects 5 to 
10% of females and is defined as excessive hair growth in females in a male 
pattern, for example excess hair growth on the jaw, neck, chest or back.2 Other 
clinical manifestations of elevated androgens include alopecia, acne and 
ovulatory and menstrual irregularities.1 Ovulatory and menstrual irregularity can 
lead to infertility, while hirsutism and the other symptoms can lead to significant 
psychological distress. Elevated androgenic hormones in females are most 
commonly caused by polycystic ovarian syndrome (PCOS) but can also be due to 
adrenal hyperplasia, androgenic medications, and androgen secreting tumors.2 
Hirsutism may also occur in the absence of elevated androgens. It is thought that 
females with idiopathic hirsutism may have increased sensitivity to androgens or 
increased numbers of androgen receptors.2  
First line treatments for hirsutism include hair removal procedures (e.g., 
shaving, laser therapy or photoepilation) and oral contraceptives. Anti-androgen 
medications are usually considered after 6 months of oral contraceptive 
treatment if the response is poor, but they can also be used first-line in addition 
to oral contraceptives.2 Monotherapy with the anti-androgenic medications 
spironolactone, finasteride, flutamide or cyproterone acetate is not recommended 
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due to the potential of teratogenic effects. Additional treatments to address 
excess androgens can also include fertility medications like clomiphene or 
gonadotropins sometimes used in conjunction with metformin.1 
Spearmint tea has been used as a non-traditional medicinal therapy for 
many years. It is often used to treat gastrointestinal distress and respiratory 
issues3 and is also a common ingredient in toothpaste and chewing gum. While 
spearmint is generally thought of as safe, there have been animal studies11-13 
revealing dose-dependent hepatotoxicity, nephrotoxicity and uterine tissue 
damage in rats, but the rat study results have not been replicated in humans. 
Moreover, reports14 of allergic contact dermatitis to spearmint leaves have been 
documented.  
The animal studies on the effects of spearmint tea on androgenic 
hormones were prompted by complaints of decreased libido in men in a specific 
region in Turkey where spearmint is grown and found as a frequent ingredient in 
tea.4 In this initial study it was found that spearmint tea reduced testosterone (T) 
and spermatogenesis while increasing luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) in male rats, prompting the more recent studies in 
humans.4 If spearmint tea is effective in lowering androgens in females it could 
be a low cost and easily accessible treatment option for management of elevated 
androgens and the resultant conditions of hirsutism, acne, infertility and hair 
loss.  
 
METHODS 
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An exhaustive search was conducted using MEDLINE-Ovid, Web of 
Science, CINAHL and Google Scholar using the keywords hirsutism, spearmint 
tea (mentha spicata) and androgens. The search was further narrowed to include 
studies only involving humans and articles in the English language. The articles 
included in this review involved females with elevated androgens or hirsutism 
who drank spearmint tea twice daily for the duration of the study. Relevant 
review articles were used for background information.  The Grading of 
Recommendations, Assessment, Development and Evaluation (GRADE) 
approach was used to assess the quality of the relevant articles.5 A search was 
conducted of the National Institute of Health clinical trials website and no 
current trials related to anti-androgenic effects of spearmint tea were noted.15 
RESULTS 
The initial search resulted in 4 articles for review.  One article was a 
literature review6 and one was a study4 on the effects of spearmint tea on rats. 
The remaining two articles included an observational study7 and a randomized 
controlled trial8 that fit the inclusion criteria. See Table I. 
 
Akdogan et al 
This study7 examined the effects of spearmint tea on androgenic hormones 
and hirsutism. Participants were recruited from an endocrinology outpatient 
clinic. The trial included 21 females with hirsutism between the ages of 18-40 
years old: 12 with PCOS and 9 with idiopathic hirsutism. The degree of hirsutism 
was graded by one physician using the Ferriman-Gallwey scoring system.9 The 
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Ferriman-Gallwey scores for the females in the study ranged from 8-23. A score 
of 8 or greater is associated with androgen excess and the maximum score is 36.7  
The trial was conducted for 5 days during the follicular phase of the 
participants’ menstrual cycles.  The following hormones were tested pre- and 
post-treatment: total testosterone (TT), free testosterone (FT), luteinizing 
hormone (LH), follicle stimulating hormone (FSH), estradiol (E2) and 
dehydroepiandrosterone sulfate (DHEA-S). They did not report a post-treatment 
Ferriman-Gallwey score, likely due to the short duration of the study. The 
participants were given a cup (250 mL) of spearmint tea to drink twice daily for 5 
days and their pre- and post-treatment lab results were compared. The study 
revealed a significant decrease in FT (p <0.05) and an increase in FSH, LH and 
E2 (p <0.05). See table II.  There were no significant decreases in TT, DHEA-S or 
the additional biochemical markers that were tested. The authors suggest that a 
decrease in FT without a decrease in TT is likely due to more T bound to the sex-
hormone binding globulin (SHBG). Since FT is the active form of T, the authors 
conclude that spearmint tea can be used as an anti-androgenic treatment for 
hirsutism.7 
 
Grant 
This randomized controlled trial8 also examined the effects of spearmint 
tea on androgen levels and hirsutism. Forty-two female patients (19-42 years old) 
with PCOS and hirsutism were recruited from an endocrinology outpatient 
setting. The Ferriman-Gallwey scores for the study group ranged from 10-24. The 
scoring was done by two separate individuals and then corroborated. In addition, 
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the participants were asked to complete the Dermatology Quality of Life Index 
(DQLI) questionnaire,10 which allowed the participants to self-report the degree 
of hirsutism with a score from 0-30. Using computer randomization, the 
participants were separated into 2 groups, 1 group received spearmint tea and the 
other received chamomile tea. Chamomile tea is not known to disrupt the 
endocrine system. The researchers were blinded and the participants were asked 
to drink 2 cups of the tea daily. This trial began on the first day after completion 
of each participants’ menstrual period and continued for 30 days. The primary 
outcome measured in this study was the level of hirsutism as measured by the 
DQLI and Ferriman-Gallwey scores at day 0 and 30. The secondary outcome was 
the androgenic hormones and gonadotropin (LH, FSH) levels measured at day 0, 
15 and 30.8 
After 30 days the spearmint tea participants reported a statistically 
significant decrease in the degree of their hirsutism by 6 points, from 17 to 11. 
However, there was no substantial change in the objective Ferriman-Gallwey 
scoring. The secondary outcome revealed a significant decrease at day 30 in both 
FT and TT (p <0.05) and an increase in both LH and FSH (p <0.05). See table 
III. The control group results revealed a slight decrease in DQLI score of 3 points 
but no significant changes in the Ferriman-Gallwey scores, androgenic hormones 
or the gonadotropins levels.8  
The author states that the primary limitation of the study was the short 
duration of only 30 days. However, with the significant decreases in FT and TT, 
the author concludes that spearmint tea may be a useful, more natural option for 
the treatment of hirsutism and androgen excess.8  
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DISCUSSION 
Elevated androgenic hormones can lead to hirsutism and other unpleasant 
symptoms. Females with elevated androgenic hormones, like those with PCOS, 
can suffer from psychological distress related to hirsutism or secondary disorders 
that can result from elevated androgens like infertility, acne, alopecia and 
irregular menses.1 While the studies7,8  have shown a reduction in androgenic 
hormones with the treatment of spearmint tea, it is unclear if it is beneficial for 
hirsutism or other symptoms related to high androgen levels.  
Both studies7,8 that were analyzed for this systematic review showed a 
reduction in FT. The Grant study,8 which was of longer duration, also showed a 
decrease in TT. It is unknown if spearmint affects the production or the function 
of androgenic hormones.8 For hirsutism, the Akdogan et al study7 did not report a 
post-treatment or follow up Ferriman-Gallwey score and the Grant study8 
observed no objective improvement in hirsutism. Both studies concluded that 
spearmint tea is likely a potential natural treatment for hirsutism and lowering 
androgenic hormones. 
The studies7,8 also revealed increases in the gonadotropin hormones, LH 
and FSH. While Akdogan et al study7 suggested the increases may be due to 
physiological changes during the follicular phase of the menstrual cycle, the 
Grant study8 showed progressive increases in LH over the 30 day study and 
significant increases in FSH from day 0 to day 30 when compared to the control 
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group. Fertility treatments for patients with high androgen levels often involve 
gonadotropins1 and this finding may lead to further studies of spearmint tea and 
the treatment of infertility in patients with hyperandrogenemia and PCOS.  
Assessment of the studies revealed serious limitations leading to low 
quality of evidence as seen in Table I. The Akdogan et al study7 did not involve a 
control group with which to compare results and differentiate between normal 
hormonal fluctuations. In addition, they did not report a post-treatment 
Ferriman-Gallwey score for rating of hirsutism, a secondary outcome of the 
study.7  Both the Akdogan et al7 and Grant8 studies were of short duration. Most 
treatments for androgen excess require at least 6 months of treatment to see 
improvement in symptoms.2 While the studies both revealed decreased 
androgens, a study of longer duration would be necessary to assess the 
improvement in hirsutism and the other symptoms associated with elevated 
androgens. Additionally, both studies report statistically significant results 
(p<0.05) but neither study reported confidence intervals.  
Despite these limitations and the low quality of evidence, spearmint is 
generally thought of as a safe, natural remedy.3 It is an affordable, easily 
accessible option for patients and 2 cups of spearmint tea daily may be useful in 
improving symptoms over time. It will be especially appealing for patients who 
are adverse to synthetic medications and interested in a more natural approach 
to their healthcare. 
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CONCLUSION  
Spearmint tea may be useful in lowering androgenic hormones for female 
patients suffering from the effects of hirsutism and other symptoms associated 
with elevated androgens. In order to see benefits in the hirsute patient, it is likely 
that longer treatment time, beyond 30 days, is necessary as is extended follow up 
with participants to measure their Ferriman-Gallwey score. It should be noted 
that the effects of spearmint tea have only been studied for 30 days and long-
term treatment may require monitoring for adverse effects. Further research is 
necessary to determine the effects of spearmint tea beyond the lowering of 
androgenic hormones and increase in gonadotropins. A study with longer 
duration of treatment with spearmint tea would be helpful, in addition to 
continued follow up to monitor for the improvement of symptoms like hirsutism 
and the other symptoms of elevated androgens that may take 6 or more months 
to improve or resolve.  While further studies will be helpful, recommending a trial 
of spearmint tea should be considered for the patient who is interested in trying a 
more natural approach to treatment first.  
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Table I: Quality Assessment of Reviewed Articles 
Outcome 
Number 
of 
studies 
Study Designs Downgrade Criteria 
Upgrade 
Criteria 
Quality 
Limitations Indirectness Inconsistency Imprecision 
Publication 
bias 
Androgenic 
Hormones 
2 
Observational, 
RCT 
Seriousa Not Serious Not Serious Seriousb,c, d Unlikely 
 
None 
 
Low 
Hirsutism 2 
Observational, 
RCT 
Seriousa Not Serious Not Serious Seriousb,c,d Unlikely 
 
None 
 
Low 
a Lack of control group in Akdogan et al study 
b Small study population (21 patients in the Akdogan et al study and 42 patients in the Grant study) 
c Short study duration (5 days in the Akdogan et al study and 30 days in the Grant study) 
d Lack of reported confidence intervals in Akdogan et al study and Grant study 
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Table II. Summary of Findings Akdogan et al 
Outcome Pre-treatment (day 0) Post-treatment (day 5) P-value 
FT (pg/mL) 5.49 +/- 2.94 3.92 +/- 2.80 <0.05 
TT (ng/mL) 0.75 +/- .40 0.67 +/- 0.35  
LH (mIU/mL) 6.34 +/- 4.53 8.04 +/-5.14 <0.05 
FSH (mIU/mL) 4.56 +/- 1.49 5.36 +/-1.84 <0.05 
E2(pg/mL)  46.50 +/- 29.01 63.43 +/- 47.57 <0.05 
DHEA-S (μg/L)  189.41 +/- 92.73 192.60 +/- 88.02  
abbreviations: free testosterone (FT), total testosterone (TT), luteinizing hormone (LH), 
follicle stimulating hormone (FSH), estradiol (E2), dihydroepiandrostenedione sulfate (DHEA-S)  
 
 
Table III. Summary of Findings Grant 
Outcome Pre-treatment (day 0) During Treatment (day 15) Post-treatment (day 30) P-value 
 Interventiona  Controlb Intervention Control Intervention Control  
FT (pg/mL) 5.12 +/- 2.14 4.98 +/- 2.84 3.70 +/- 2.58 4.70 +/- 1.98 3.64 +/- 2.67 4.49 +/- 1.67 <0.05 
TT (ng/mL) 0.81 +/- 0.39 0.87 +/- 0.40 0.80 +/- 0.22 0.81 +/- 0.21 0.62 +/- 0.34 0.80 +/- 0.14 <0.05 
LH (mIU/mL) 5.25 +/- 3.2 5.47 +/- 2.7 5.99 +/- 4.1 5.59 +/- 4.1 7.23 +/- 3.9 5.23 +/- 2.8 <0.05 
FSH (mIU/mL) 5.12 +/- 1.98 5.67 +/- 1.99 4.57 +/- 1.67 5.52 +/- 1.42 6.10 +/- 2.1 5.59 +/- 2.4 <0.05 
DHEA-S (μg/L) 184.5 +/- 82.1 179.5 +/- 85.3 187.2 +/- 79.1 183.2 +/- 76.1 183.3 +/- 87.8 183.3 +/- 82.8  
FG score (0-36) 17 (12-22) 17 (12-22)   16 (10-22) 16 (11-22)  
DQLI (o-30) 17 (10-24) 18 (10-24)   11 (8-18) 15 (9-18) <0.05 
abbreviations: free testosterone (FT), total testosterone (TT), luteinizing hormone (LH), follicle stimulating hormone (FSH), estradiol (E2), 
dihydroepiandrostenedione sulfate (DHEA-S), Ferriman-Gallwey (FG), dermatology quality of life index (DQLI) 
 
a: Invention (n=21): spearmint tea  
b: Control (n=20): chamomile tea 
 
